CRSP Operating Cash Flow (Statement)
Crispr Therapeutics Ag · Operating Cash Flow (Statement)
CRSP Operating Cash Flow (Statement)
Latest reported-$369.58Mperiod ending
CRSP Cash from Operations (-$4.79M → -$369.58M)
Annual operating cash flow (statement)
High-resolution chart · PNG
CRSP operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -345,014,000 | |
| -142,774,000 | |
| -260,375,000 | |
| -495,741,000 | |
| 538,972,000 | |
| -238,366,000 | |
| 56,677,000 | |
| -96,239,000 | |
| -70,097,000 | |
| -55,310,000 | |
| 59,428,000 | |
| -4,793,000 |